SomaPlex slides from Protein BioTechnologies, for screening protein biomarkers in human tumors, are arrays prepared from a vast collection of total protein lysates derived from numerous human tissues representing a range of cancer subtypes. Detailed clinical and histopathology is available for each sample.
Protein from patient-matched normal and tumor tissue is robotically-spotted on specially-treated glass slides that are compatible with colorimetric, chemiluminescent or fluorescent protein detection systems. Microarrays are supplied with custom, low-volume incubation chambers and ZeptoBlock Protein Microarray-optimized blocking buffer.
www.proteinbiotechnologies.com
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 4, April, 2008, pp. 48.
Filed Under: Genomics/Proteomics
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-268x170.jpg)
